Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 2 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| LAMP2 | ENSG00000005893 | 0.00 | 0.00 | 0 | 0 |
| ITGA2B | ENSG00000005961 | 0.00 | 0.00 | 0 | 0 |
| MAP3K14 | ENSG00000006062 | 0.00 | 0.18 | 0 | 1 |
| TAC1 | ENSG00000006128 | 0.00 | 0.00 | 0 | 0 |
| TNFRSF12A | ENSG00000006327 | 0.00 | 0.00 | 0 | 0 |
| MAP3K9 | ENSG00000006432 | 0.00 | 0.47 | 0 | 3 |
| KDM7A | ENSG00000006459 | 0.35 | 0.00 | 2 | 0 |
| ALDH3B1 | ENSG00000006534 | 0.00 | 0.00 | 0 | 0 |
| CCL26 | ENSG00000006606 | 0.00 | 0.00 | 0 | 0 |
| DBF4 | ENSG00000006634 | 0.13 | 0.00 | 1 | 0 |
| TBXA2R | ENSG00000006638 | 0.00 | 0.00 | 0 | 0 |
| ARSD | ENSG00000006756 | 0.00 | 0.00 | 0 | 0 |
| PRSS21 | ENSG00000007038 | 0.00 | 0.00 | 0 | 0 |
| PROM1 | ENSG00000007062 | 0.00 | 0.00 | 0 | 0 |
| SCN4A | ENSG00000007314 | 0.00 | 0.00 | 0 | 0 |
| SELE | ENSG00000007908 | 0.00 | 0.00 | 0 | 0 |
| NOX1 | ENSG00000007952 | 0.00 | 0.00 | 0 | 0 |
| PSMB1 | ENSG00000008018 | 0.00 | 0.80 | 0 | 3 |
| CDKL5 | ENSG00000008086 | 0.13 | 0.00 | 1 | 0 |
| CAMK1G | ENSG00000008118 | 0.00 | 0.15 | 0 | 1 |
|
Showing page 2 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.